Syra Health Corp. Class A Common Stock (SYRA)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 0 | 1 | 6 | 6 | 8 | 7 | 8 | - |
| Operating profit | $m | -1 | - | ||||||
| Net profit | $m | -0 | -0 | -2 | -3 | -4 | -1 | - | - |
| EPS reported | $ | -0.08 | -0.02 | ||||||
| Operating cashflow per share | $ | -0.04 | 0.06 | ||||||
| Capex per share | $ | 0.00 | 0.00 | ||||||
| FCF per share | $ | -0.04 | 0.06 | ||||||
| Free cash flow | $m | -0 | 0 | ||||||
| Net debt | $m | -1 | -2 | ||||||
| Book value equity | $m | 2 | 3 | ||||||
| Book value per share | $ | 0.18 | 0.19 | ||||||
| Number of shares | m | 11.85 | 13.55 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.49 | 0.39 | ||||||
| P/S LTM | x | 0.14 | 0.13 | ||||||
| P/FCF LTM | x | -2.28 | 9.30 | ||||||
| EV/EBITDA LTM | x | 0.52 | -3.09 | ||||||
| EV/Sales LTM | x | -0.06 | 0.62 | ||||||
| Earnings Yield LTM | % | -87.94% | -2.42% | ||||||
| FCF Yield | % | -43.94% | +10.75% | ||||||
| Quality | |||||||||
| ROE | % | -42.72% | -8.06% | ||||||
| ROIC | % | -40.34% | -9.85% | ||||||
| Operating margin | % | -12.51% | -3.14% | ||||||
| Gross margin | % | +34.43% | +33.20% | ||||||
| FCF/Sales | % | -6.20% | +9.89% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -9.47% | +1.35% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -3.11 | 0.73 | ||||||
| Net Debt/EBITDA | x | 1.71 | 17.91 | ||||||
| EBIT/Net interest | x | -68.15 | -19.20 | ||||||
| Net debt/market cap | % | +11.42% | +0.82% | ||||||
| Net debt/Equity | x | -0.71 | -0.78 | ||||||
| Gross debt/equity | x | 0.07 | 0.06 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Syra Health Corp. is a U.S.-based healthcare services company offering a diverse portfolio of solutions. Their core offerings span health education, population health management, behavioral and mental health support, healthcare workforce solutions, and digital health advancements. Within health education, the company provides medical communications, patient-focused learning programs, and professional training. Its population health management segment features analytics-as-a-service, epidemiological studies, and health equity analysis tools. Additionally, Syra Health is actively developing "Syrenity," an on-demand telehealth platform specifically designed for mental health services. The firm further extends its reach through healthcare staffing provisions and comprehensive digital health solutions. These digital solutions encompass digital transformation initiatives, cloud and cybersecurity services, artificial intelligence applications, patient engagement tools, and various health-related mobile applications. Syra Health serves a broad spectrum of clients, including mental health facilities and organizations, government entities, integrated health networks, managed care organizations, and pharmaceutical manufacturers. Established in 2020, the company's headquarters are located in Carmel, Indiana.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Syra Health Corp. Class A Common Stock (SYRA)
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Syra Health Corp. is a U.S.-based healthcare services company offering a diverse portfolio of solutions. Their core offerings span health education, population health management, behavioral and mental health support, healthcare workforce solutions, and digital health advancements. Within health education, the company provides medical communications, patient-focused learning programs, and professional training. Its population health management segment features analytics-as-a-service, epidemiological studies, and health equity analysis tools. Additionally, Syra Health is actively developing "Syrenity," an on-demand telehealth platform specifically designed for mental health services. The firm further extends its reach through healthcare staffing provisions and comprehensive digital health solutions. These digital solutions encompass digital transformation initiatives, cloud and cybersecurity services, artificial intelligence applications, patient engagement tools, and various health-related mobile applications. Syra Health serves a broad spectrum of clients, including mental health facilities and organizations, government entities, integrated health networks, managed care organizations, and pharmaceutical manufacturers. Established in 2020, the company's headquarters are located in Carmel, Indiana.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free